This session will explore the accomplishments and challenges of the creation and the implementation of national strategies in four countries with varying HIV epidemic profiles: South Africa, Swaziland, Brazil and the USA.
HIV/AIDSSee more about HIV/AIDS
- view as grid
- view as list
This session will focus on the ongoing HIV epidemic of the USA and Canada. It will describe the epidemiology of HIV in the region, and explore the health disparities, which continue to undermine HIV prevention and care efforts.
This session will explore ways of quickening the pulse of the AIDS movement at this critical time when the AIDS response is under threat and activism is being marginalized.
AIDS 2012: Press Conference: Labs for Life: PEPFAR, CDC and BD Announce New Labs Strengthening Initiative
BD (Becton, Dickinson and Company) and the U.S. Presidentâ€™s Emergency Plan for AIDS Relief (PEPFAR) through the U.S. Department of Health and Human Servicesâ€™ Centers for Disease Control and Prevention (CDC) will unveil the results of a five-year collaboration that improved overall laboratory systems and services in African countries severely affected by HIV/AIDS and tuberculosis (TB).
AIDS 2012: The Future of HIV Prevention, Health and Human Rights in Gay, other MSM and Transgender Communities: Towards More Effective Approaches with ICTs in a Web 2.0 World
This session critically explores why existing public health approaches to mobilizing communities for HIV prevention may be ineffective in achieving improved health and human rights.
Directed at clinicians, scientists and programme managers interested in HIV in women, this symposia session will address key topics in the continuum of HIV infection in women throughout the lifespan (excluding fertility and pregnancy which are addressed in other sessions).
The use of contraception is a powerful public health intervention which reduces maternal mortality, improves infant and child outcomes, impacts on PMTCT and empowers women.
This session will focus on the major shift in the architecture of global development assistance since Gleneagles, with particular reference to the current crisis around the Global Fund and declining interest in some rich countries in the epidemic.
From Promise to Programmes: Treatment as Prevention
Insurance Coverage and Access to HIV Testing and Treatment: Considerations for Individuals at Risk for Infection and for Those with Undiagnosed Infection
Of the estimated 1.2 million people living with HIV/AIDS in the United States, approximately 500,000 are not receiving care for their disease. This includes an estimated 250,000 people who do not know they are HIV positive. This article reviews data on insurance coverage and access to HIV testing and treatment,…